tiprankstipranks
Trending News
More News >
Candel Therapeutics (CADL)
NASDAQ:CADL
US Market

Compare Candel Therapeutics (CADL) vs. Competitors

Compare
423 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Candel Therapeutics
$5.74
$334.88M
-10.26
-14.33%
4 Buy
1 Hold
0 Sell
Strong Buy
Tonix Pharma
$15.08
$234.79M
-0.02
-60.25%
2 Buy
0 Hold
0 Sell
Moderate Buy
Quantum-Si
$1.20
$265.05M
-42.31%
2 Buy
1 Hold
0 Sell
Moderate Buy
Humacyte
$1.00
$198.79M
-4.19
-78.35%
4 Buy
0 Hold
0 Sell
Strong Buy
Monte Rosa Therapeutics
$21.13
$1.76B
69.19
263.06%
8 Buy
0 Hold
0 Sell
Strong Buy
Inhibrx Biosciences Inc
$85.32
$1.07B
-7.23
504.41%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CADL
Candel Therapeutics
5.74
-1.22
-17.53%
TNXP
Tonix Pharma
18.29
-19.21
-51.23%
QSI
Quantum-Si
1.20
-0.76
-38.78%
HUMA
Humacyte
1.00
-3.72
-78.81%
GLUE
Monte Rosa Therapeutics
21.13
14.68
227.60%
INBX
Inhibrx Biosciences Inc
73.98
60.43
445.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts